In a series of flip-flops on Friday, the United Kingdom suspended the enrollment of new patients into the hydroxychloroquine arm of its massive RECOVERY trial, one of the largest randomised COVID-19 clinical trials in the world, after preliminary data showed “no benefit” for COVID-19 patients receiving the drug. The suspension of the trial came just […] Continue reading ->
A day ahead of a major pledging event, Gavi-the Vaccine Alliance has received some US $70 million in pledges from a broad range of corporations, foundations, initiatives and individual philanthropists to modernise, streamline and strengthen its delivery of vaccines to children in the world’s poorest countries over the next 15 years. Meanwhile, Médecins sans Frontières […] Continue reading ->
US President Donald Trump announced on Friday he was terminating the US’ relationship with the World Health Organization. Trump’s declaration came hours after WHO’s celebratory launch of a new ‘Solidarity Call to Action ,’ urging countries to make patents and data for COVID-19 treatments and vaccines freely available as ‘global public goods.’ Some 37 countries […] Continue reading ->
France rolled back recommendations on the use of hydroxychloroquine, a malaria drug, for severe COVID-19 patients, just two days after the World Health Organization suspended its large multinational hydroxychloroquine trial. Meanwhile, the United Kingdom has authorized the use of remdesivir for severe cases of COVID-19. The drug showed modest potential to shorten the length of […] Continue reading ->
This story was updated 4 June to reflect the Lancet study’s retraction. Enrollment of new patients in the hydroxychloroquine (HCQ) arm of the World Health Organization’s Global COVID-19 Solidarity Trial will be put on pause, as the trial’s oversight committee reviews all available data on COVID-19 and hydroxychloroquine, WHO Director-General Dr. Tedros Adhanom Ghebreyesus said […] Continue reading ->